B Meyer-Wyss

Summary

Affiliation: St. Claraspital
Country: Switzerland

Publications

  1. ncbi [Esophageal and intestinal stents]
    B Meyer-Wyss
    St Claraspital, Intern Medizinische Abteilung, Basel
    Ther Umsch 60:219-23. 2003
  2. ncbi Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
    B Meyer-Wyss
    St Clara Spital, Basel, Switzerland
    J Viral Hepat 13:457-65. 2006

Detail Information

Publications2

  1. ncbi [Esophageal and intestinal stents]
    B Meyer-Wyss
    St Claraspital, Intern Medizinische Abteilung, Basel
    Ther Umsch 60:219-23. 2003
    ..The most frequent complications are stent dislocation and stent obstruction due to food impaction or tumour overgrowth...
  2. ncbi Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
    B Meyer-Wyss
    St Clara Spital, Basel, Switzerland
    J Viral Hepat 13:457-65. 2006
    ..In combination with ribavirin, PEG-I alpha-2b 1.0 microg/kg was as effective as 1.5 microg/kg but was better tolerated in patients with chronic hepatitis C and up to moderate fibrosis...